2026 NPPES data Hematology & Oncology Physician NPI 1235462128 MD
Verify on CMS →

NANDINI IGNATIUS, MD

Hematology & Oncology Physician in NEWARK, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
591
Medicare Part D claims · 130 beneficiaries · Hematology & Oncology Physician avg: 847
MIPS score
88.0404/100
▲ 5 pts above national avg 83.1 · [object Object]
Industry payments
$953.82
51 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

NANDINI IGNATIUS, MD reported a CMS MIPS final score of 88.0404/100 — above the 83.1 national average — and filed 591 Medicare Part D claims in 2023.

88.0404/100
MIPS score · +5 vs avg
591
Part D claims, 2023
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

NANDINI IGNATIUS, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

88 Top 44% higher than 56% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

NANDINI IGNATIUS, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about NANDINI IGNATIUS, MD?

High performer (top quartile)

NPI registry status

Active

Issued 09/10/2009

NPI 1235462128

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

591 30% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

88.0404/100 4.940400000000011% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in New Jersey

How Hematology & Oncology Physician compares to other specialties among New Jersey providers

New Jersey providers

Hematology & Oncology Physician share within New Jersey

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within New Jersey

Medicare quality performance — MIPS

NANDINI IGNATIUS, MD's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

High performer (top quartile)
MIPS Final Score
88.0404/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 88.0404/100 vs national avg 83.1

0%100%National avg83%88%
MIPS final score (Hematology & Oncology Physician) — 88.0404/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

NANDINI IGNATIUS, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 205 S ORANGE AVE, NEWARK, NJ, 07103, with a listed phone of (973) 972-6257. NPI 1235462128 was issued on 09/10/2009. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what IGNATIUS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 591 prescription claims written by this provider, covering 130 Medicare beneficiaries and totaling roughly $953K in drug spend, with an opioid prescribing rate of 3.2%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 88.0404/100 for the 2023 performance year (Quality 69.1643), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

205 S ORANGE AVE
NEWARK, NJ 07103

Provider Details

NPI 1235462128
Specialty Hematology & Oncology Physician
Credentials MD
Gender Female
NPI Issued 09/10/2009

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

88.0404
Final Score
Avg: 83.1
69.1643
Quality
100
Promoting Interoperability

Reporting: Individual

Hospital and facility affiliations

Facilities where NANDINI IGNATIUS, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

TITAN HEALTH PARTNERS LLC
ROBBINSVILLE, NJ

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for NANDINI IGNATIUS, MD. Source: openpaymentsdata.cms.gov.

Total received

$954

Largest payer

Janssen Biotech, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

591
Total Claims
$953K
Total Drug Cost
130
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
856
Total Day Supply
24,081
Generic Drug Cost
$10K
Opioid Claims
19 (3.2% rate)
Antibiotic Claims
18

Patient Demographics

Average Patient Age
74.4 years
Avg HCC Risk Score
1.89
Gender Split
59% female / 41% male
Age Distribution
<65: 11, 65-74: 52, 75-84: 53, 85+: 14

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What NANDINI IGNATIUS, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Eliquis
Apixaban
69
Hydroxyurea
59
Letrozole
48
Xarelto
Rivaroxaban
40
Ibandronate Sodium
20
Warfarin Sodium
19
Alendronate Sodium
17
Prednisone
16
Anastrozole
15
Dexamethasone
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How NANDINI IGNATIUS, MD fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

NANDINI IGNATIUS, MD's 591 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as IGNATIUS.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is NANDINI IGNATIUS, MD's specialty?
NANDINI IGNATIUS, MD specializes in Hematology & Oncology Physician and practices in NEWARK, New Jersey. Credentials: MD.
How much does NANDINI IGNATIUS, MD prescribe under Medicare Part D?
In 2023, NANDINI IGNATIUS, MD wrote 591 Medicare Part D claims totaling $953K in drug costs for 130 beneficiaries.
What is NANDINI IGNATIUS, MD's Medicare quality score?
NANDINI IGNATIUS, MD has a CMS MIPS Final Score of 88.0404/100 (Quality: 69.1643). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is NANDINI IGNATIUS, MD located?
NANDINI IGNATIUS, MD is located at 205 S ORANGE AVE, NEWARK, NJ, 07103. Phone: (973) 972-6257.
What is NANDINI IGNATIUS, MD's NPI number?
NANDINI IGNATIUS, MD's National Provider Identifier (NPI) is 1235462128, issued on 09/10/2009.
Does NANDINI IGNATIUS, MD prescribe opioids?
Yes, NANDINI IGNATIUS, MD had 19 opioid claims in 2023 with an opioid prescribing rate of 3.2%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does NANDINI IGNATIUS, MD prescribe most often?
Based on 2023 Medicare Part D data, NANDINI IGNATIUS, MD's most frequently prescribed drugs include Eliquis, Hydroxyurea, Letrozole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does NANDINI IGNATIUS, MD accept Medicare?
NANDINI IGNATIUS, MD appears in CMS Medicare data with 591 Part D claims and 130 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify NANDINI IGNATIUS, MD's credentials?
NANDINI IGNATIUS, MD's NPI is 1235462128 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology